Cellectis S.A. (0WA2)
LSE
2.85
+0.08 (+3.00%)
Closed
Aug 25, 2026
Day's Range
2.832.85
52 wk Range
2.074.84
Financial Statements - 0WA2 - Cellectis S.A.
Revenue
72.94M▲ 75.8%
Net Income
-67.59M▼ 83.9%Net Margin -92.7%
EBITDA
-3.51M▲ 87.6%
Free Cash Flow
-42.93M▼ 324.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 72.94M | 41.50M | 755K | 19.17M | 30.34M | 51.05M |
| Cost of Goods | 9.79M | 9.18M | 737K | 1.77M | 1.84M | 1.95M |
| Gross Profit | 63.15M | 32.32M | 18K | 17.39M | 28.50M | 49.10M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -33.07M | -59.55M | -97.30M | -89.66M | -103.48M | -42.31M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -36.33M | 18.96M | -16.35M | 6.06M | 9.74M | -10.59M |
| Pre Tax Income | -68.01M | -36.76M | -116.46M | -98.60M | -96.75M | -53.58M |
| Income Tax | -423K | 0 | 371K | 87K | 0 | 0 |
| Net Income | -67.59M | -36.76M | -108.44M | -114.03M | -125.10M | -97.48M |
| EPS Basic | -0.67 | -0.41 | -1.77 | -2.33 | -1.91 | -1.91 |
| EPS Diluted | -0.67 | -0.41 | -1.77 | -2.33 | -1.91 | -1.91 |
| Basic Shares Outstanding | 100.27M | 90.56M | 62.02M | 47.40M | 44.17M | 44.23M |
| Diluted Shares Outstanding | 100.27M | 90.56M | 62.02M | 47.40M | 44.17M | 44.23M |
| Ebit | -59.90M | -29.30M | -111.15M | -94.81M | -92.58M | -51.17M |
| Ebitda | -3.51M | -28.43M | -76.28M | -82.43M | -88.16M | -32.75M |
| Net Income Continuous Operations | -67.59M | -36.76M | -116.83M | -98.68M | -96.74M | -53.58M |
| Minority Interests | 0 | 0 | 7.38M | 7.89M | 10.91M | 16.40M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
